ADMA - ADMA Biologics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADMA is currently covered by 4 analysts with an average price target of $25.09. This is a potential upside of $3.91 (18.46%) from yesterday's end of day stock price of $21.18.

ADMA Biologics's activity chart (see below) currently has 25 price targets and 52 ratings on display. The stock rating distribution of ADMA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.76% with an average time for these price targets to be met of 842.71 days.

Highest price target for ADMA is $26, Lowest price target is $14, average price target is $25.09.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 08-Nov-2024. First documented stock forecast 09-Sep-2015.

Currently out of the existing stock ratings of ADMA, 25 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$26

$4.82 (22.76%)

$18

15 days ago
(08-Nov-2024)

14/15 (93.33%)

$3.04 (13.24%)

298

Buy

$20

$-1.18 (-5.57%)

$20

2 months 3 days ago
(20-Sep-2024)

8/8 (100%)

$0.02 (0.10%)

139

Buy

$14

$-7.18 (-33.90%)

$12

5 months 3 days ago
(20-Jun-2024)

8/8 (100%)

$3.29 (30.72%)

520

Buy

$6

$-15.18 (-71.67%)

1 years 3 months 13 days ago
(10-Aug-2023)

4/4 (100%)

$1.69 (39.21%)

784

Buy

$4

$-17.18 (-81.11%)

$7

4 years 17 days ago
(06-Nov-2020)

6/6 (100%)

$2.09 (109.42%)

1736

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADMA (ADMA Biologics) average time for price targets to be met?

On average it took 842.71 days on average for the stock forecasts to be realized with a an average price target met ratio 84.76

Which analyst has the current highest performing score on ADMA (ADMA Biologics) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on ADMA (ADMA Biologics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ADMA (ADMA Biologics)?

Jason Kolbert works at DAWSON JAMES and has 5 price targets and 5 ratings on ADMA

Which analyst is the currently most bullish on ADMA (ADMA Biologics)?

Raghuram Selvaraju with highest potential upside - $4.82

Which analyst is the currently most reserved on ADMA (ADMA Biologics)?

Leland Gershell with lowest potential downside - -$17.18

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?